Skip to Main Content

Paper Details

Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Proc Natl Acad Sci U S A
18
2022
Author NameAffiliation
Jorge A GutierrezMemorial Sloan Kettering Cancer Center
John T PoirierPerlmutter Cancer Center, New York University Langone Health
Charles M Rudin
Charles M RudinMemorial Sloan Kettering Cancer Center
Charles M RudinMemorial Sloan Kettering Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
Yu ChenMemorial Sloan Kettering Cancer Center
Michael J MorrisMemorial Sloan Kettering Cancer Center
Michael J Morris
  • 1 - 9

Datasets

Release 1.2